Anti-CXCR4 antibodies

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S139100, C424S143100, C530S387100, C530S387300, C530S387900, C530S388100, C530S388220

Reexamination Certificate

active

08003102

ABSTRACT:
The present invention provides antibodies that bind human CXCR4 and are characterized as having high affinity and strong neutralizing properties. The antibodies of the invention are useful in the treatment of tumorigenesis, including tumor growth, invasion, angiogenesis, or metastasis.

REFERENCES:
patent: 5776457 (1998-07-01), Lee et al.
patent: 5840856 (1998-11-01), Chuntharapai et al.
patent: 5994515 (1999-11-01), Hoxie
patent: 6863887 (2005-03-01), Murphy et al.
patent: 6949243 (2005-09-01), Mueller et al.
patent: 7138496 (2006-11-01), Hua et al.
patent: 2004/0132642 (2004-07-01), Hwang
patent: 2004/0209837 (2004-10-01), Kishimoto et al.
patent: 2007/0003558 (2007-01-01), von Andrian et al.
patent: 2007/0059308 (2007-03-01), Hua et al.
patent: 2010/0055088 (2010-03-01), Peled et al.
patent: 9217497 (1992-10-01), None
patent: 9948528 (1999-09-01), None
patent: 9950461 (1999-10-01), None
patent: 0138352 (2001-05-01), None
patent: 03066830 (2003-08-01), None
patent: 2004059285 (2004-07-01), None
patent: 2004074506 (2004-09-01), None
patent: 2006089141 (2006-08-01), None
patent: 2008060367 (2008-05-01), None
Carnec, X., et al., “Anti-CXCR4 Monoclonal Antibodies Recognizing Overlapping Epitopes Differ Significantly in Their Ability to Inhibit Entry of Human Immunodeficiency Virus Type 1”, Journal of Virology, 2005, 1930-1933, 79;3.
Muller, A., et al., “Involvement of chemokine receptors in breast cancer metastasis”, Nature, 2001, 50-56, 410.
Vermont-Desroches C., et al., “Evaluation of anti CXCR-4 Antibodies”, Diaclone Technical Document, CR4.1, Version 1-05.01, 2001.
Ghannadan, M., et al., “Detection of Novel CD Antigens on the Surface of Human Mast Cells and Basophils”, International Archives of Allergy and Immunology, 2002, 299-307, 127.
Yang, H., et al., “Antibody to CD14 like CXCR4-specific antibody 12G5 could inhibit CXCR4-dependent chemotaxis and HIV Env-mediated cell fusion”, Immunology Letters, 2003, 27-30, 88.
Paul, “Fv Structure and Diversity in Three Dimensions”, Fundamental Immunology, 3rd Edition, 1993, pp. 292-295.
Rudikoff, et al, Proc. Natl. Acad. Sci. USA, Mar. 1982, 1979-1983, 79(6).
Colman P.M., Research in Immunology, 1994, 33-36, 145.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Anti-CXCR4 antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-CXCR4 antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-CXCR4 antibodies will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2652562

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.